* BGA XXXVI B. III.3 (c) and XXXVI / 1 II.B.2 (c) and BGW XXXVI / 1 of the RFA.
* 21 CFR Ch. 1, Sec 176,170 and 176,180 of the FDA (maximum dose 1.5% on dry).
* Ch II.1.2.2m VGB Netherlands.
* CEE / CEPAC 3.2.E (c)
Its use is particularly suitable as a protector on stretchers and examination tables in care centers, clinics and hospitals.
| Ref | Weight gr/m2 | Thickness mm | Resist. Traction* kN/m | Absorption Klemm* mm / 10 min. |
| 44 | 0.170 | 0.90 / 0.85 | 40 - 50 |